2014

2014.11.04 Commencement of mutual sales of products from the ReproCELL group companies

Commencement of mutual sales of products from the ReproCELL group companies

2014.10.03 ReproCELL Completed the Acquisition of iPS Cell Business Unit of Stemgent, Inc.

ReproCELL Completed the Acquisition of iPS Cell Business Unit of Stemgent, Inc.(PDF)

2014.09.29 ReproCELL Launches the Operation of Cell Innovation Partners, L.P., Corporate Venture Capital Fund, with Shinsei Bank, Limited

ReproCELL Launches the Operation of Cell Innovation Partners, L.P., Corporate Venture Capital Fund, with Shinsei Bank, Limited

2014.09.08 ReproCELL Acquires the iPS Cell Business Unit of Stemgent, Inc.

ReproCELL Acquires the iPS Cell Business Unit of Stemgent, Inc.

2014.08.04 ReproCELL Expects Synergy and Business Benefits through the Acquisitions of Reinnervate and BioServe

ReproCELL Expects Synergy and Business Benefits through the Acquisitions of Reinnervate and BioServe

2014.07.08 ReproCELL Inc. announces business collaboration with KOKEN CO., LTD

Yokohama, Kanagawa, Japan ReproCELL Inc. (ReproCELL, CEO: Chikafumi Yokoyama, Ph.D. JASDAQ: 4978) announced today that ReproCELL has completed a distributorship agreement with KOKEN CO., LTD (KOKEN, Tokyo, Japan, President: Yuzo Tarumi, Ph.D.). ReproCELL will sell KOKEN’s collagen products globally outside Japan. In the half century since founding in 1959, KOKEN has become a world-class specialist in the development and manufacture of silicone materials to replace human skin and other parts of the body, along with various types of medical plastics, life simulation models for medical education, and Atelocollagen products ranging from cosmetics to medical-use materials. ReproCELL will promote KOKEN’s tissue/cell culture collagen products, AteloCell® including 3D tissue/cell culture scaffolds and […]

2014.07.08 ReproCELL supports CTSI Stem Cell Core Retreat on Jul 21, 2014.

ReproCELL supports CTSI Stem Cell Core Retreat as an official sponsor on Jul 21, 2014. – Flyer – Program

2014.06.30 Application to the ReproCELL’s Innovative Research Grant Program 2014 is closed on June 30, 2014.

Application to the ReproCELL’s Innovative Research Grant Program 2014 is closed on June 30, 2014.

2014.01.28 ReproCELL, Inc., Shinsei Bank to establish joint venture fund

ReproCELL, Inc., Shinsei Bank to establish joint venture fund 1 billion JPY to target unlisted iPS cell and regenerative medical bio-venture within and outside Japan. Click here for more information.

2014.01.28 ReproCELL, Inc. announces the establishment of a subsidiary

The new subsidiary will accelerate R&D efforts and enhance our competitiveness in iPS cell and regenerative medicine segment, thereby contributing to future drug discovery and healthcare business generation. Click here for more information.

  • «
  • 1
  • »